Abstract

Sjögren syndrome (SS) is a chronic autoimmune disease characterized by inflammation of salivary and lacrymal glands, causing oral and ocular dryness [1]. The syndrome was named by Swedish ophthalmologist Henrik Sjögren, who identified it in 1933. SS prevalence ranges between 0. 5 % and 3 % and the syndrome is more likely to affect females over 40 years old, especially in menopause [2, 3]. It is a slowly progressing, non-life-threatening disease with a 10-year cumulative survival rate of over 90 % [4].

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call